Metraipolis › archive › dc_012c3bed4d7b
Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study — Europe PMC PMID:42147116
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42147116
- DOI
- 10.3389/fendo.2026.1818019
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T21:25:06.684Z
- SHA-256 of the archived text
3ecdabae8024c3a4fba265dbb57eb8d1cd738d116c48db2b70e498fd3b33351e- Stable URL of this page
https://metraipolis.com/documento/dc_012c3bed4d7b
How to cite
Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study — Europe PMC PMID:42147116 — Europe PMC (en), https://europepmc.org/article/MED/42147116 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_012c3bed4d7b (Metraipolis archive dc_012c3bed4d7b, sha256 3ecdabae8024c3a4fba265dbb57eb8d1cd738d116c48db2b70e498fd3b33351e)
BibTeX
@misc{dc012c3bed4d7b,
title = {Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study — Europe PMC PMID:42147116},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42147116},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_012c3bed4d7b; sha256 3ecdabae8024c3a4fba265dbb57eb8d1cd738d116c48db2b70e498fd3b33351e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147116. Agents can read the archived copy with the MCP tool read_document.